News Releases
- Chugai Files for Additional Indication of Avastin for the Treatment of Neurofibromatosis Type 2
- Chugai Obtains Regulatory Approval for Tecentriq for the Additional Indication of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type, a Rare Disease
- Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary
